Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. == Medical use == Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes.
Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes. == Medical use == Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes.
Source: Wikipedia "Lixisenatide" · CC BY-SA 4.0
Share this article: X · Bluesky